文献速递烧伤创面修复

NovoSorb可降解临时基质在严重烧伤创面愈合与真皮再生中的前瞻性临床研究

Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study.
PubMed 文献 · Burns · 2021-07-31

这项多中心前瞻性临床研究评估了合成聚氨酯真皮模板BTM用于深度烧伤创面一期真皮修复的效果。

要点

  • BTM适用于大面积烧伤自体供皮不足时的真皮修复。
  • 延迟皮片移植后皮片成活率均值81.9%,BTM成活率均值88.6%。
  • 即使存在感染迹象,恰当管理下BTM仍可能成功整合。

核心结论

  • BTM作为真皮替代物在深度烧伤患者中安全有效,可支持真皮再生与后续皮片移植。

主要发现

  • 皮片成活率均值81.9%,BTM成活率均值88.6%。
  • 恰当管理下,即使有感染迹象BTM仍可成功整合。
  • BTM应用后12个月内瘢痕质量随时间改善。

关键数值与推荐

  • 主要终点为BTM移植后7-10天刃厚皮片成活百分比,均值81.9%。
  • 次要终点包括BTM成活百分比(均值88.6%)、感染与不良事件发生率及12个月瘢痕质量。

临床怎么用

  • 对大面积深度烧伤自体供皮不足者,可考虑BTM行一期真皮修复后延迟植皮。
  • 围手术期需积极管理感染,以利BTM整合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: For extensive burns, autologous donor skin may be insufficient for early debridement and grafting in a single stage. A novel, synthetic polyurethane dermal template (NovoSorb® Biodegradable Temporising Matrix, BTM) was developed to address this need. The aim of this study was to evaluate use of BTM for primary dermal repair after deep burn injury. METHODS: A multicentre, prospective, clinical study was conducted from September 2015 to May 2018. The primary endpoint was % split skin graft take over applied BTM at 7-10 days after grafting. Secondary endpoints included % BTM take, incidence of infection and adverse events, and scar quality to 12 months after BTM application. RESULTS: Thirty patients were treated with BTM and delayed split skin grafting. The % graft take had a mean of 81.9% and % BTM take had a mean of 88.6%, demonstrating effective integration of BTM. When managed appropriately, it was possible for BTM to integrate successfully despite findings suggestive of infection. Scar quality improved over time. DISCUSSION: These results provide additional clinical evidence on the safety and performance of BTM as an effective dermal substitute in the treatment of patients with deep burn injuries.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Lo CH, Brown JN, Dantzer EJG, et al. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study. Burns. 2021. PMID: 34407914. doi:10.1016/j.burns.2021.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。